Dhanpat Jain, MD

Professor of Pathology and of Medicine (Digestive Diseases); Director, Program in Gastrointestinal and Liver Pathology; Director, Fellowship in Gastrointestinal and Liver Pathology

Physician Biography

I specialize in livers diseases, particularly in liver cancer. Together with my colleagues, we analyze liver tissue specimens obtained from liver biopsies or from surgery to help in understanding important aspects of the tumor. We use state-of-the-art technologies to stage the tumor, characterize its biological features and suggest possible targets for innovative treatment. We participate in the liver cancer tumor board and provide our input on every case in which tissue samples are needed.

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: MD to MD Consult

Patient Care Organizations

Pathology: Medical & Surgical Pathology: GI & Liver Pathology

Internal Medicine: Digestive Diseases: Inflammatory Bowel Disease Program

Liver Cancer Program

Yale Medicine

Office of Cooperative Research

Clinical Trials

Conditions Study Title
Addictive Behaviors, Alcohol Addiction, Diseases of the Digestive System - Liver Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis (ENCORE-NF)
Diseases Of The Digestive System, Diseases of the Digestive System - Liver Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

Edit this profile

Contact Info

Dhanpat Jain, MD
Office Location
Department of PathologyYale New Haven Hospital
20 York Street, Ste EP2-609

New Haven, CT 06510
View on map...
Mailing Address
310 Cedar Street
PO Box 208023

New Haven, CT 06520-8023

Curriculum Vitae

Lysosomal acid lipase deficiency (LAL-D)

Liver showing micro-vesicular steatosis and ceroid laden macrophages in the portal area in a patient with LAL-D.

Von-Meyenburg comples

These are benign bile ductular proliferations that I suspect are colonic adenoma equivalent in the liver, and give rise to sporadic Cholangiocarcinoma.